APA
Click to copy
Jaén-Moreno, M. J., Feu, N., Redondo-Écija, J., Montiel, F. J., Gómez, C., del Pozo, G. D., … Sarramea, F. (2019). Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk — TIMER—): study protocol for a randomized controlled trial. Trials.
Chicago/Turabian
Click to copy
Jaén-Moreno, M. J., N. Feu, Justa Redondo-Écija, F. J. Montiel, C. Gómez, G. D. del Pozo, J. Alcalá, et al. “Smoking Cessation Opportunities in Severe Mental Illness (Tobacco Intensive Motivational and Estimate Risk — TIMER—): Study Protocol for a Randomized Controlled Trial.” Trials (2019).
MLA
Click to copy
Jaén-Moreno, M. J., et al. “Smoking Cessation Opportunities in Severe Mental Illness (Tobacco Intensive Motivational and Estimate Risk — TIMER—): Study Protocol for a Randomized Controlled Trial.” Trials, 2019.
BibTeX Click to copy
@article{m2019a,
title = {Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk — TIMER—): study protocol for a randomized controlled trial},
year = {2019},
journal = {Trials},
author = {Jaén-Moreno, M. J. and Feu, N. and Redondo-Écija, Justa and Montiel, F. J. and Gómez, C. and del Pozo, G. D. and Alcalá, J. and Gutiérrez-Rojas, L. and Balanzá-Martínez, V. and Chauca, Geli Marie and Carrión, L. and Osuna, M. I. and Sánchez, M. D. and Caro, Inmaculada and Ayora, M. and Valdivia, F. and López, María Soledad Pérez and Poyato, J. and Sarramea, F.}
}
BackgroundThere is an increased risk of premature death in people with severe mental illness (SMI). Respiratory disorders and cardiovascular disease are leading causes of increased mortality rates in these patients, and tobacco consumption remains the most preventable risk factor involved. Developing new tools to motivate patients towards cessation of smoking is a high priority. Information on the motivational value of giving the lung age and prevention opportunities is unknown in this high-risk population.Methods/designThis article describes in detail a protocol developed to evaluate an intensive motivational tool, based on the individual risks of pulmonary damage and prevention opportunities. It is designed as a randomized, 12-month, follow-up, multicenter study. A minimum of 204 smokers will be included, aged 40 years and older, all of whom are patients diagnosed with either schizophrenia or bipolar disorder (BD). Chronic obstructive pulmonary disease (COPD) will be evaluated using spirometry, and the diagnosis will then be validated by a pneumologist and the lung age estimated. Based on this value, a motivational message about prevention will be issued for the intervention group, which will be reinforced by individualized text messages over a period of 3 months.The efficacy of the method and the pulmonary damage variables will be evaluated: smoking cessation at the end of follow-up will be confirmed by cooximetry, and the COPD diagnosis and the severity of the staging for disease will be assessed.DiscussionIn the context of community care, screening and early detection of lung damage could potentially be used, together with mobile technology, in order to produce a prevention message, which may provide patients with SMI with a better chance of quitting smoking.Trial registrationClinicalTrials.gov, ID: NCT03583203. Registered on 11 July 2018.Trial status: recruitment.